Simplex Trading’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-51,241
| Closed | -$1.67M | – | 10124 |
|
|
2025
Q3 | $1.22M | Buy |
+51,241
| New | +$963K | ﹤0.01% | 2838 |
|
|
2025
Q1 | – | Sell |
-13,242
| Closed | -$269K | – | 9724 |
|
|
2024
Q4 | $230K | Sell |
13,242
-27,219
| -67% | -$481K | ﹤0.01% | 4372 |
|
|
2024
Q3 | $566K | Sell |
40,461
-40,528
| -50% | -$422K | ﹤0.01% | 3466 |
|
|
2024
Q2 | $665K | Buy |
80,989
+69,591
| +611% | +$469K | ﹤0.01% | 3352 |
|
|
2024
Q1 | $87K | Buy |
+11,398
| New | +$96.2K | ﹤0.01% | 5734 |
|
|
2023
Q2 | – | Sell |
-4,793
| Closed | -$87.2K | – | 9977 |
|
|
2023
Q1 | $107K | Buy |
+4,793
| New | +$102K | ﹤0.01% | 5081 |
|
|
2022
Q4 | – | Sell |
-4,256
| Closed | -$90.2K | – | 10475 |
|
|
2022
Q3 | $104K | Sell |
4,256
-3,548
| -45% | -$91.7K | ﹤0.01% | 5473 |
|
|
2022
Q2 | $189K | Buy |
7,804
+7,044
| +927% | +$177K | ﹤0.01% | 4686 |
|
|
2022
Q1 | $19K | Sell |
760
-3,712
| -83% | -$98.6K | ﹤0.01% | 8315 |
|
|
2021
Q4 | $138K | Sell |
4,472
-10,799
| -71% | -$304K | ﹤0.01% | 5732 |
|
|
2021
Q3 | $238K | Buy |
15,271
+383
| +3% | +$7.04K | ﹤0.01% | 5330 |
|
|
2021
Q2 | $217K | Buy |
14,888
+12,800
| +613% | +$252K | ﹤0.01% | 5558 |
|
|
2021
Q1 | $52K | Buy |
+2,088
| New | +$57.7K | ﹤0.01% | 6574 |
|
|
2020
Q3 | – | Sell |
-1,236
| Closed | -$24K | – | 8545 |
|
|
2020
Q2 | $25K | Buy |
+1,236
| New | +$19.7K | ﹤0.01% | 6052 |
|
|
2020
Q1 | – | Sell |
-132
| Closed | -$1.99K | – | 8303 |
|
|
2019
Q4 | $1K | Sell |
132
-4,411
| -97% | -$56.3K | ﹤0.01% | 7134 |
|
|
2019
Q3 | $52K | Buy |
+4,543
| New | +$75.1K | ﹤0.01% | 4989 |
|
|
2019
Q1 | – | Sell |
-17,548
| Closed | -$388K | – | 7880 |
|
|
2018
Q4 | $397K | Buy |
+17,548
| New | +$437K | ﹤0.01% | 2444 |
|
|
2018
Q3 | – | Sell |
-444
| Closed | -$12.7K | – | 8086 |
|
|
2018
Q2 | $12K | Buy |
+444
| New | +$11.8K | ﹤0.01% | 6241 |
|
|
2018
Q1 | – | Sell |
-839
| Closed | -$20K | – | 6893 |
|
|
2017
Q4 | $17K | Buy |
+839
| New | +$19.2K | ﹤0.01% | 3456 |
|
|
2017
Q1 | – | Sell |
-19,331
| Closed | -$378K | – | 6802 |
|
|
2016
Q4 | $365K | Sell |
19,331
-1,200
| -6% | -$24.5K | 0.02% | 705 |
|
|
2016
Q3 | $459K | Buy |
20,531
+15,719
| +327% | +$299K | 0.03% | 550 |
|
|
2016
Q2 | $85K | Buy |
4,812
+4,034
| +519% | +$65.3K | 0.01% | 1602 |
|
|
2016
Q1 | $10K | Sell |
778
-2,471
| -76% | -$37.5K | ﹤0.01% | 3486 |
|
|
2015
Q4 | $62K | Buy |
+3,249
| New | +$64.9K | ﹤0.01% | 1757 |
|
|
2015
Q3 | – | Sell |
-4,796
| Closed | -$142K | – | 6215 |
|
|
2015
Q2 | $158K | Buy |
+4,796
| New | +$131K | 0.01% | 926 |
|
|
2015
Q1 | – | Sell |
-3,544
| Closed | -$54K | – | 5613 |
|
|
2014
Q4 | $43K | Buy |
+3,544
| New | +$36.7K | 0.01% | 1479 |
|
Other funds holding TVTX
AC
PA
VCM
NAMI
Simplex Trading's TVTX Position: Q4 2025 in Review
Simplex Trading sold out of Travere Therapeutics (TVTX) in Q4 2025, closing a stake of 51,241 shares — an estimated $1.67M sold.
Simplex Trading first reported a position in TVTX in Q4 2014 and held it in 26 quarters. The position peaked at $1.22M in Q3 2025. 278 funds tracked by Wall St. Rank hold TVTX as of Q4 2025.
- Simplex Trading reported no remaining Travere Therapeutics position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 51,241 Travere Therapeutics shares in Q4 2025, an estimated $1.67M.
- Simplex Trading first reported a position in Travere Therapeutics in Q4 2014 and held it in 26 quarters.
- Simplex Trading's Travere Therapeutics position peaked at $1.22M in Q3 2025.
- 278 funds tracked by Wall St. Rank held Travere Therapeutics as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.